Tuesday, November 10, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

A pharmacy made its first sale of a compounded peptide. The FDA has not approved these drugs.

Corexa is working through pricing and intends to market its compounded-peptide offering to prescribing

DO
By Daniel Okafor · Regulatory Correspondent
Nov 9 06:00 ETSource: Stock Titan

From the source

A pharmacy made its first sale of a compounded peptide. The FDA has not approved these drugs.

Corexa is working through pricing and intends to market its compounded-peptide offering to prescribing physicians.

Read at stocktitan.net
PeptiPrescribed peptides from $99/moSee all →